基因组肖像:反思瘤对治疗的反应
1Memorial Sloan Kettering Cancer Center, New York, New York.
概括
研究人员在匹配的组织样本中确定了独特的信号通路和基因组特征. 这种概况有助于通过揭示对雄激素受体信号抑制剂 (ARSI) 耐药性的机制来指导治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 雄激素受体信号抑制剂 (ARSI) 在治疗前列腺癌方面至关重要.
- 了解ARSI的耐药性机制对于改善患者的治疗结果至关重要.
- 在ARSI治疗前后匹配的组织样本提供了宝贵的见解.
研究的目的:
- 识别与ARSI治疗相关的独特信号通路和基因组特征.
- 在前列腺癌中建立指导治疗的全面概况.
- 为了研究研究ARSI耐药性的最大的潜在生物标本储存协议.
主要方法:
- 在ARSI启动之前和之后,从患者身上收集和注释匹配的组织样本.
- 在收集的标本中分析信号通路和基因组特征.
- 未来生物标本银行协议的实施.
主要成果:
- 在ARSI治疗期间激活的不同信号通路的识别.
- 发现与治疗反应或耐药性相关的特定基因组特征.
- 建立基于分子变化的治疗指导资料.
结论:
- 识别的分子形状可以指导个性化治疗选择.
- 了解耐药机制是开发新型治疗策略的关键.
- 这项研究为未来对ARSI耐药性的研究提供了基础.
相关概念视频
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


